UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000013316 |
|---|---|
| Receipt number | R000015535 |
| Scientific Title | Randomized phase II trial evaluating the efficacy and safety of standard care +/- continuous gefitinib treatment beyond progression in patients with advanced NSCLC after 1st line treatment with gefitinib(TORG1019) |
| Date of disclosure of the study information | 2014/03/03 |
| Last modified on | 2014/11/11 13:15:47 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/03/03 14:13:57 | ||
| 2 | Update | 2014/07/18 10:35:17 | Email |
|
| 3 | Update | 2014/07/18 10:37:17 | Name of person sending information Name of person sending information |
|
| 4 | Update | 2014/11/11 13:14:08 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 5 | Update | 2014/11/11 13:15:47 | Recruitment status |
